30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Sebelius Kathleen

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
7 71% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sebelius Kathleen's trades of Humacyte Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-20 2026-05-19
US Humacyte Inc (HUMA)
B Purchase
85,795 +17.4%
46.06
US$2,910,375 		85,795 +17.4% 46.06 US$2,910,375
2025-07-16 2025-07-16
PrS Proposed sale
11,918
216.58
US$3,385,554 		11,918 216.58 US$3,385,554
2025-04-08 2025-04-08
US Humacyte Inc (HUMA)
B Purchase
99,882 +16.3%
191.11
US$2,440,048 		99,882 +16.3% 191.11 US$2,440,048
2024-09-11 2024-09-10
US Humacyte Inc (HUMA)
S Sale
1,548 -3.6%
5.39
US$8,344 		1,548 -3.6% 5.39 US$8,344
2024-09-11 2024-09-10
US Humacyte Inc (HUMA)
S Sale
3,634 -8.3%
5.41
US$19,660 		3,634 -8.3% 5.41 US$19,660
2024-09-10 2024-09-10
US Humacyte Inc (HUMA)
PrS Proposed sale
5,182
5.41
US$28,012 		5,182 5.41 US$28,012
2019-06-14 2019-06-12
B Purchase
4,500 +900.0%
8.96
US$40,320 		4,500 +900.0% 8.96 US$40,320
2019-06-14 2019-06-12
B Purchase
300 +150.0%
8.92
US$2,676 		300 +150.0% 8.92 US$2,676
2019-06-14 2019-06-12
B Purchase
100 +100.0%
8.93
US$893 		100 +100.0% 8.93 US$893
2019-06-14 2019-06-12
B Purchase
100 +inf%
8.95
US$895 		100 +inf% 8.95 US$895